Infection Control News

SAN FRANCISCO — A universal syphilis screening program identified more cases of syphilis than programs targeting specific patient populations, such as pregnant women and patients already receiving blood draws, researchers found.

SAN FRANCISCO — Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, baseline suppressive therapies among adults with HIV.

SAN FRANCISCO — Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that could transform the landscape of HIV prevention.

SAN FRANCISCO — HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled from decades of studies, researchers found.

An antibiotic stewardship intervention at urgent care centers was associated with lower rates of inappropriate prescribing for bronchitis and viral upper respiratory infections, although active clinician engagement is necessary, researchers found.

The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza vaccines, an HHS official confirmed Thursday.

In January, Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States.

Three bovine veterinary practitioners had evidence prior infection with highly pathogenic H5N1 avian influenza despite having no apparent contact with infected cows, according to a study published in MMWR.

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ease dengue virus symptoms when given before and after infection.